The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
This report from the Kaiser Family Foundation and the Joint United Nations Programme on HIV/AIDS (UNAIDS) evaluates international efforts to finance the response to the AIDS epidemic. The annual funding analysis finds donor governments disbursed US$7.86 billion toward the AIDS response in low-and middle-income countries in 2012, essentially unchanged from the US$7.63 billion level in 2011 after adjusting for inflation.
This brief presents key findings from a Kaiser Family Foundation review and analysis of the policy and financing landscape where U.S. humanitarian assistance and global health assistance meet. It also summarizes a July 2013 roundtable discussion convened by the Foundation focusing on opportunities, challenges, and potential next steps for more effective coordination between humanitarian assistance and global health programs.
This report provides an analysis of U.S.-based non-governmental organizations (NGOs) that received global health funding from the U.S. government (USG) during FY 2013. It specifically focuses on funding provided to NGOs by the U.S. Agency for International Development (USAID), the largest implementer of global health activities among USG agencies and departments.
This report finds that funding for global malaria control and elimination activities has risen from US$871 million in 2005 to US$2.6 billion in 2013. However, total funding is significantly below US$5.1 billion, the goal set by the Global Malaria Action Plan, which is a framework endorsed by world leaders in 2008 to reach global malaria reduction targets.
Additionally, support for malaria research and development (R&D) activities in 2013 was estimated to be US$549 million, below the estimated annual need of US$750-900 million and the lowest level of funding since 2007, the first year of available data.
A fair amount of attention was given recently to projections made by the Chief Actuary of the Centers for Medicare and Medicaid Services (CMS) about the new health reform law, and how they compare to previous estimates by the Congressional Budget Office (CBO).
Enacted in 2003, Medicare’s Part D prescription drug benefit reflected an unprecedented and controversial new approach for Medicare, relying exclusively on private plans to provide health coverage and including an unusual gap in coverage. This analysis by Kaiser researchers examines in detail how the new model has worked since its launch almost four years ago.
Drew Altman, Larry Levitt, Gary Claxton My colleagues have worked on this column with me and I invited them to join me as authors.
This March 2007 issue brief, commissioned by the Kaiser Family Foundation, provides a basic introduction to the reimbursement system for private Medicare drug plans.
In his latest column for The Wall Street Journal's Think Tank, Drew Altman discusses a recent success in global HIV treatment and how successes may get less attention than they deserve because of prevailing attitudes about the corruption in foreign aid. All previous columns by Drew Altman are available.
In this Policy Insight, Jen Kates and Josh Michaud look at the prospects for the future of U.S. global health policy, examining whether long-term bipartisan support may be tested during a time of political transition, and identifying key areas of consensus among policymakers and the public.
© 2025 KFF